Ouathek Ouerfelli

11PUBLICATIONS
96CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 01, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

|Nov 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

|Jul 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Jacob A Boyer, Ezra Y Rosen, Malvika Sharma

|Mar 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase.

Amrita Singh, Samantha Ottavi, Inna Krieger

|Oct 27, 2023
APR-246 increases tumor antigenicity independent of p53.

Judith Michels, Divya Venkatesh, Cailian Liu

|Apr 12, 2022
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents.

Thapi D Rao, Mengyao Xu, Stephanie Eng

Pageof 2

Frequent Collaborators

2 joint publications

Kristjan H Gretarsson

2 joint publications

John Mosior

2 joint publications

Guangli Yang

2 joint publications

Ben S Gold